Skip to main content
Photo of  Emily K. Curran, MD

Emily K. Curran, MD

Assistant Professor

Internal Medicine | College of Medicine

Education/Credentials
  • BA: Stanford University
  • MD: Stanford University School of Medicine
  • Residency: University of Chicago Medical Center
  • Fellowship: University of Chicago Medical Center
  • Fellowship: University of Chicago
Board Certifications & Licenses

American Board of Internal Medicine (Hematology) (Certification Date: 20171031)
American Board of Internal Medicine (Certification Date: 20110815)
American Board of Internal Medicine (Medical Oncology) (Certification Date: 20161027)

Specialties

Hematology
Internal Medicine
Medical Oncology

Contact Information

Clinical Interests

Hematology and Oncology

Leukemia

Acute Lymphocytic Leukemia

Acute Myeloid Leukemia

Amyloidosis

Castleman Disease

Chronic Lymphocytic Leukemia

Chronic Myelogenous Leukemia

Lymphadenopathy

Lymphoma

M Protein

Macrocytosis

Macroglobulinemia

Mantle Cell Lymphoma

Mastocytosis

Mediastinal Adenopathy

Monoclonal gammopathy

Monoclonal protein

Mycosis Fugoides

Myelodysplastic Syndrome

Myeloma

Myeloproliferative Disorder

Paraproteinemia

Plasma Cell Disorder

Polycythemia vera

Proteinuria

Sideroblastic anemia

T-cell lymphoma

M-Spike

Summary

Current Role
Emily K. Curran, MD, is an Assistant Professor in the Department of Medicine, Section of Hematology & Oncology at the UC College of Medicine. 


Current Clinical Focus and Interests
Dr. Curran’s clinical interest focuses on the care of patients with hematologic malignancies and, in particular, acute leukemia. Her particular area of expertise is in treatment of adolescent and young adult (AYA) patients with hematologic malignancies. She is a member of the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO).


Summary of Background/Previous Work History, Education and AchievementsDr. Curran is a graduate of Stanford University and Stanford University School of Medicine. She completed her residency training in Internal Medicine and fellowship in Hematology & Oncology at the University of Chicago. She completed an additional fellowship in Clinical Pharmacology and Pharmacogenomics at the University of Chicago.
 

Peer Reviewed Publications

Curran, Emily; Stock, Wendy 2019. Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL. Blood, 133 16, 1715-1719

Wang, Amy Y; Weiner, Howard; Green, Margaret; Chang, Hua; Fulton, Noreen; Larson, Richard A; Odenike, Olatoyosi; Artz, Andrew S; Bishop, Michael R; Godley, Lucy A; Thirman, Michael J; Kosuri, Satyajit; Churpek, Jane E; Curran, Emily; Pettit, Kristen; Stock, Wendy; Liu, Hongtao 2018. A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. Journal of hematology & oncology, 11 1, 4

Curran, Emily K; Godfrey, James; Kline, Justin 2017. Mechanisms of Immune Tolerance in Leukemia and Lymphoma. Trends in immunology, 38 7, 513-525

Salahudeen, Ameen Abdulla; Patel, Manali I; Baas, Paul; Curran, Walter J; Bradley, Jeffrey D; Gandara, David R; Goss, Glenwood D; Mok, Tony S; Ramalingam, Suresh S; Vokes, Everett E; Malik, Shakun M; Wakelee, Heather A 2017. Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe. Clinical lung cancer, 18 1, 5-12

Stinchcombe, Thomas E; Zhang, Ying; Vokes, Everett E; Schiller, Joan H; Bradley, Jeffrey D; Kelly, Karen; Curran, Walter J; Schild, Steven E; Movsas, Benjamin; Clamon, Gerald; Govindan, Ramaswamy; Blumenschein, George R; Socinski, Mark A; Ready, Neal E; Akerley, Wallace L; Cohen, Harvey J; Pang, Herbert H; Wang, Xiaofei 2017. Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 25, 2885-2892

Yap, Kai Lee; Furtado, Larissa V; Kiyotani, Kazuma; Curran, Emily; Stock, Wendy; McNeer, Jennifer L; Kadri, Sabah; Segal, Jeremy P; Nakamura, Yusuke; Le Beau, Michelle M; Gurbuxani, Sandeep; Raca, Gordana 2017. Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & lymphoma, 58 4, 950-958

Curran, Emily; Chen, Xiufen; Corrales, Leticia; Kline, Douglas E; Dubensky, Thomas W; Duttagupta, Priyanka; Kortylewski, Marcin; Kline, Justin 2016. STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell reports, 15 11, 2357-66

Curran, Emily; Corrales, Leticia; Kline, Justin 2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia. Frontiers in oncology, 5 , 83

Curran, Emily; Stock, Wendy 2015. How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood, 125 24, 3702-10

Curran, Emily; Smith, Sonali M 2014. Phosphoinositide 3-kinase inhibitors in lymphoma. Current opinion in oncology, 26 5, 469-75

Jain, Nitin; Curran, Emily; Iyengar, Neil M; Diaz-Flores, Ernesto; Kunnavakkam, Rangesh; Popplewell, Leslie; Kirschbaum, Mark H; Karrison, Theodore; Erba, Harry P; Green, Margaret; Poire, Xavier; Koval, Greg; Shannon, Kevin; Reddy, Poluru L; Joseph, Loren; Atallah, Ehab L; Dy, Philip; Thomas, Sachdev P; Smith, Scott E; Doyle, L Austin; Stadler, Walter M; Larson, Richard A; Stock, Wendy; Odenike, Olatoyosi 2014. Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 20 2, 490-8

Curran, Emily K; Le, Gem M; Sainani, Kristin L; Propp, Jennifer M; Fisher, Paul Graham 2009. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. Journal of neuro-oncology, 95 1, 81-85

Curran, Emily K; Sainani, Kristin L; Le, Gem M; Propp, Jennifer M; Fisher, Paul G 2009. Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry. Pediatric blood & cancer, 52 1, 60-4

Partap, Sonia; Curran, Emily K; Propp, Jennifer M; Le, Gem M; Sainani, Kristin L; Fisher, Paul Graham 2009. Medulloblastoma incidence has not changed over time: a CBTRUS study. Journal of pediatric hematology/oncology, 31 12, 970-1

Lynch, Thomas J; Bogart, Jeffrey A; Curran, Walter J; DeCamp, Malcolm M; Gandara, David R; Goss, Glenwood; Henschke, Claudia I; Jett, James R; Johnson, Bruce E; Kelly, Karen L; Le Chevalier, Thierry; Mulshine, James L; Scagliotti, Giorgio V; Schiller, Joan H; Shaw, Alice; Thatcher, Nick; Vokes, Everett E; Wood, Douglas E; Hart, Carol 2005. Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clinical cancer research : an official journal of the American Association for Cancer Research, 11 13 Pt 2, 4981s-4983s

Muffly L.;Curran E. 12-06-2019. Pediatric-inspired protocols in adult acute lymphoblastic leukemia: Are the results bearing fruit? Hematology (United States), 2019 1, 17-23

Derman B.A.;Streck M.;Wynne J.;Christ T.N.;Curran E.;Stock W.;Knoebel R.W. 02-23-2020. Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphi Leukemia and Lymphoma, 61 3, 614-622

Lyu J.;Curran E.;Ji Y. 01-01-2018. Bayesian adaptive design for finding the maximum tolerated sequence of doses in multicycle dose-find JCO Precision Oncology, 2 ,

Curran E.;Corrales L.;Kline J. 01-01-2015. Targeting the innate immune system as immunotherapy for acute myeloid leukemia Frontiers in Oncology, 5 APR,